Pervasis' Unattributed VC Round

Pervasis raised a round of funding on January 23, 2008.

Pervasis Therapeutics, Inc. is developing biologically active therapeutics to regulate vascular repair and restore blood flow to critical organs and vasculature. The company's flagship product, Vascu…

Articles about Pervasis' Unattributed VC Round: